Alex Marsh

Q: What is Alex Marsh email address?

Email Alex Marsh at ladyalexmtb@gmail.com and amarsh@windgapmedical.com. This email is the most updated Alex Marsh email found in 2026.

Q: How to contact Alex Marsh?

To contact Alex Marsh send an email to ladyalexmtb@gmail.com or amarsh@windgapmedical.com. (updated on October 30, 2024)

Senior Director Chemistry Manufacturing and Controls (CMC) at Verona Pharma | Raleigh-Durham-Chapel Hill Area

About Alex Marsh

Alex Marsh serves as the Senior Director of Chemistry, Manufacturing, and Controls (CMC) at Verona Pharma, where he plays a pivotal role in advancing inhalation product development for innovative respiratory therapies. With over twenty years of comprehensive experience spanning pre-clinical to commercial stages, Alex leads global multi-disciplinary teams in the design, development, and validation of drug product formulations, including Dry Powder Inhalers (DPI), Metered Dose Inhalers (MDI), and nebulised formulations. His expertise encompasses the entire lifecycle of pharmaceutical product development, from feasibility studies through to clinical trials manufacturing and supply, ensuring that each phase meets the rigorous standards required for regulatory submissions, including Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA).

At Verona Pharma, Alex has spearheaded key projects that focus on the scale-up and technical transfer of manufacturing processes, leveraging his deep understanding of manufacturing operations and regulatory affairs. His strategic approach to process development not only enhances product quality but also optimizes operational efficiency, enabling the successful transition from laboratory to commercial production. Alex's commitment to fostering an energizing and engaging team environment has been instrumental in driving innovation and collaboration across departments, ensuring that Verona Pharma remains at the forefront of respiratory therapy advancements.

With a robust background in R&D, validation, and the development of Standard Operating Procedures (SOPs), Alex Marsh exemplifies the blend of scientific acumen and operational excellence necessary for navigating the complexities of pharmaceutical development in the inhalation space. His leadership continues to inspire teams to achieve ambitious goals while maintaining a steadfast focus on patient outcomes and safety.

Alex Marsh Work